SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 1st, 2022 • Synthetic Biologics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 1st, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 28, 2022, between Synthetic Biologics, Inc., a Nevada corporation (the “Company”), and MSD Credit Opportunity Master Fund, L.P. ( including its successors and assigns, the “Purchaser”).